Upgrade to SI Premium - Free Trial

AngioDynamics (ANGO) PT Lowered to $34 at Canaccord Genuity

January 7, 2022 7:21 AM
Canaccord Genuity analyst William Plovanic lowered the price target on AngioDynamics (NASDAQ: ANGO) to $34.00 (from $37.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles